|
|||||
|
|
Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618 |
|
| Authors: | Susanne M. Arnold James Moon Stephen K. Williamson James N. Atkins Sai-Hong I. Ou Michael LeBlanc Susan G. Urba |
| Affiliation: | 1. University of Kentucky, Lexington, KY, USA 7. Markey Cancer Center, 800 Rose Street, cc445, Lexington, KY, 40536, USA 2. Southwest Oncology Group Statistical Center, Seattle, WA, USA 3. University of Kansas Medical Center, Kansas City, KS, USA 4. Southeast Cancer Control Consortium, Inc. CCOP, Winston-Salem, NC, USA 5. University of California at Irvine, Orange, CA, USA 6. University of Michigan Medical Center, Ann Arbor, MI, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |